BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37391169)

  • 1. RNA Sequencing Reveals Novel Oncogenic Fusions and Depicts Detailed Fusion Transcripts of FN1-FGFR1 in Phosphaturic Mesenchymal Tumors.
    Liu X; Yin X; Li D; Li K; Zhang H; Lu J; Zhou L; Gao J; Wang J; Wu H; Liang Z
    Mod Pathol; 2023 Oct; 36(10):100266. PubMed ID: 37391169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Klotho Overexpression Is Frequently Associated With Upstream Rearrangements in Fusion-Negative Phosphaturic Mesenchymal Tumors of Bone and Sinonasal Tract.
    Lee JC; Hsieh TH; Kao YC; Tsai CF; Huang HY; Shih CY; Song HL; Oda Y; Chih-Hsueh Chen P; Pan CC; Sittampalam K; Petersson F; Konishi E; Chiu WY; Chen CF; Carpenter TO; Lu TP; Chang CD; Huang SC; Folpe AL
    Mod Pathol; 2023 Dec; 36(12):100336. PubMed ID: 37742927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumour.
    Lee JC; Jeng YM; Su SY; Wu CT; Tsai KS; Lee CH; Lin CY; Carter JM; Huang JW; Chen SH; Shih SR; Mariño-Enríquez A; Chen CC; Folpe AL; Chang YL; Liang CW
    J Pathol; 2015 Mar; 235(4):539-45. PubMed ID: 25319834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of FN1-FGFR1 and novel FN1-FGF1 fusion genes in a large series of phosphaturic mesenchymal tumors.
    Lee JC; Su SY; Changou CA; Yang RS; Tsai KS; Collins MT; Orwoll ES; Lin CY; Chen SH; Shih SR; Lee CH; Oda Y; Billings SD; Li CF; Nielsen GP; Konishi E; Petersson F; Carpenter TO; Sittampalam K; Huang HY; Folpe AL
    Mod Pathol; 2016 Nov; 29(11):1335-1346. PubMed ID: 27443518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report: Novel NIPBL-BEND2 fusion gene identified in osteoblastoma-like phosphaturic mesenchymal tumor of the fibula.
    Sakai T; Okuno Y; Murakami N; Shimoyama Y; Imagama S; Nishida Y
    Front Oncol; 2022; 12():956472. PubMed ID: 36686800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent overexpression of klotho in fusion-negative phosphaturic mesenchymal tumors with tumorigenic implications.
    Lee CH; Su SY; Sittampalam K; Chen PC; Petersson F; Kao YC; Carpenter TO; Hsieh TH; Konishi E; Tsai JW; Billings SD; Folpe AL; Lee JC
    Mod Pathol; 2020 May; 33(5):858-870. PubMed ID: 31792355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic and molecular features of six cases of phosphaturic mesenchymal tumor.
    Sun L; Dehner C; Kenney J; McNulty SM; Zhu X; Pfeifer JD; Maluf HM; Chrisinger JSA
    Virchows Arch; 2021 Apr; 478(4):757-765. PubMed ID: 33151412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcified chondroid mesenchymal neoplasms with FN1-receptor tyrosine kinase gene fusions including FGFR2, FGFR1, MERTK, NTRK1, and TEK: a molecular and clinicopathologic analysis.
    Liu YJ; Wang W; Yeh J; Wu Y; Mantilla JG; Fletcher CDM; Ricciotti RW; Chen EY
    Mod Pathol; 2021 Jul; 34(7):1373-1383. PubMed ID: 33727696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. From epistaxis to bone pain-report of two cases illustrating the clinicopathological spectrum of phosphaturic mesenchymal tumour with fibroblast growth factor receptor 1 immunohistochemical and cytogenetic analyses.
    Mok Y; Lee JC; Lum JH; Petersson F
    Histopathology; 2016 May; 68(6):925-30. PubMed ID: 26407099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synovial chondromatosis and soft tissue chondroma: extraosseous cartilaginous tumor defined by FN1 gene rearrangement.
    Amary F; Perez-Casanova L; Ye H; Cottone L; Strobl AC; Cool P; Miranda E; Berisha F; Aston W; Rocha M; O'Donnell P; Pillay N; Tirabosco R; Baumhoer D; Hookway ES; Flanagan AM
    Mod Pathol; 2019 Dec; 32(12):1762-1771. PubMed ID: 31273315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor receptor 1 (FGFR1) expression in phosphaturic mesenchymal tumors.
    Tajima S; Fukayama M
    Int J Clin Exp Pathol; 2015; 8(8):9422-7. PubMed ID: 26464698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hiding in plain sight: Gene panel and genetic markers reveal 26-year undiagnosed tumor-induced osteomalacia of the rib concurrently misdiagnosed as X-linked hypophosphatemia.
    Colazo JM; DeCorte JA; Gillaspie EA; Folpe AL; Dahir KM
    Bone Rep; 2021 Jun; 14():100744. PubMed ID: 33490314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphaturic Mesenchymal Tumors: Clinicopathologic, Immunohistochemical and Molecular Analysis of 22 Cases Expanding their Morphologic and Immunophenotypic Spectrum.
    Agaimy A; Michal M; Chiosea S; Petersson F; Hadravsky L; Kristiansen G; Horch RE; Schmolders J; Hartmann A; Haller F; Michal M
    Am J Surg Pathol; 2017 Oct; 41(10):1371-1380. PubMed ID: 28614212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphaturic Mesenchymal Tumor Involving the Head and Neck: A Report of Five Cases with FGFR1 Fluorescence In Situ Hybridization Analysis.
    Wasserman JK; Purgina B; Lai CK; Gravel D; Mahaffey A; Bell D; Chiosea SI
    Head Neck Pathol; 2016 Sep; 10(3):279-85. PubMed ID: 26759148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphaturic mesenchymal tumor without osteomalacia: additional confirmation of the "nonphosphaturic" variant, with emphasis on the roles of FGF23 chromogenic in situ hybridization and FN1-FGFR1 fluorescence in situ hybridization.
    Sent-Doux KN; Mackinnon C; Lee JC; Folpe AL; Habeeb O
    Hum Pathol; 2018 Oct; 80():94-98. PubMed ID: 29514106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor-Induced Osteomalacia.
    Hartley IR; Roszko KL; Li X; Pozo K; Streit J; Del Rivero J; Magone MT; Smith MR; Vold R; Dambkowski CL; Collins MT; Gafni RI
    JBMR Plus; 2022 Aug; 6(8):e10661. PubMed ID: 35991529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic profiling of a chondroblastoma-like osteosarcoma/malignant phosphaturic mesenchymal tumor of bone reveals a homozygous deletion of CDKN2A, intragenic deletion of DMD, and a targetable FN1-FGFR1 gene fusion.
    Saba KH; Cornmark L; Rissler M; Fioretos T; Åström K; Haglund F; Rosenberg AE; Brosjö O; Nord KH
    Genes Chromosomes Cancer; 2019 Oct; 58(10):731-736. PubMed ID: 31066955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of FN1-fused calcified chondroid mesenchymal neoplasm of the hand with novel FGFR3 partner gene.
    Georgantzoglou N; Shen G; Jour G; Linos K
    Genes Chromosomes Cancer; 2023 Apr; 62(4):237-241. PubMed ID: 36504176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NCOA4-RET and TRIM27-RET Are Characteristic Gene Fusions in Salivary Intraductal Carcinoma, Including Invasive and Metastatic Tumors: Is "Intraductal" Correct?
    Skálová A; Ptáková N; Santana T; Agaimy A; Ihrler S; Uro-Coste E; Thompson LDR; Bishop JA; Baněčkova M; Rupp NJ; Morbini P; de Sanctis S; Schiavo-Lena M; Vanecek T; Michal M; Leivo I
    Am J Surg Pathol; 2019 Oct; 43(10):1303-1313. PubMed ID: 31162284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel HOOK3-FGFR1 fusion gene involved in activation of the NF-kappaB pathway.
    Zhang X; Wang F; Yan F; Huang D; Wang H; Gao B; Gao Y; Hou Z; Lou J; Li W; Yan J
    Cancer Cell Int; 2022 Jan; 22(1):40. PubMed ID: 35081975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.